Form 4 Tracker
Hims & Hers Health, Inc.
HIMS

68 insider filings · Latest: Aug 12, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 16, 2026Apr 20 8:38 PMOluyemi OkupeChief Financial Officer
Sale
36,922$25.90$956.1K281,867(D)

View →

Apr 20, 2026Apr 20 5:19 PMBoughton Soleil
Proposed Sale
9,463$30.00$283.9K

View →

Apr 6, 2026Apr 7 9:14 PMOluyemi OkupeChief Financial Officer
Sale
3,975$19.98$79.4K318,789(D)

View →

Apr 6, 2026Apr 6 10:03 PMOluyemi Okupe
Proposed Sale
240,560$20.33$4.9M

View →

Mar 20, 2026Mar 24 10:09 PMOluyemi OkupeChief Financial Officer
Sale
9,217$23.77$219.1K318,789(D)

View →

Mar 17, 2026Mar 18 8:17 PMIrene BecklundPAO
Sale
5,529$24.69$136.5K8,752(D)

View →

Mar 17, 2026Mar 18 8:17 PMSoleil BoughtonChief Legal Officer
Sale
4,812$24.69$118.8K308,831(D)

View →

Mar 17, 2026Mar 18 8:17 PMMichael ChiChief Operating Officer
Sale
97,289$24.69$2.4M407,282(D)

View →

Mar 17, 2026Mar 17 4:41 PMBoughton Soleil
Proposed Sale
4,812$24.69$118.8K

View →

Mar 17, 2026Mar 17 3:39 PMBecklund Irene
Proposed Sale
5,529$24.69$136.5K

View →

Mar 17, 2026Mar 17 2:06 PMChi Michael
Proposed Sale
97,289$24.69$2.4M

View →

Feb 27, 2026Mar 2 9:18 PMSoleil BoughtonChief Legal Officer
Sale
4,651$15.21$70.7K440,972(D)

View →

Feb 27, 2026Feb 27 3:09 PMBoughton Soleil
Proposed Sale
4,651$15.21$70.7K

View →

Feb 3, 2026Feb 4 9:13 PMOluyemi OkupeChief Financial Officer
Sale
5,262$26.44$139.1K91,617(D)

View →

Jan 20, 2026Jan 21 9:23 PMOluyemi OkupeChief Financial Officer
Sale
9,067$30.34$275.1K91,617(D)

View →

Jan 20, 2026Jan 20 9:34 PMOluyemi Okupe
Proposed Sale
27,204$30.47$828.9K

View →

Dec 22, 2025Dec 22 10:00 PMOluyemi Okupe
Proposed Sale
32,160$35.05$1.1M

View →

Dec 17, 2025Dec 17 3:26 PMCarroll Patrick Harrison
Proposed Sale
10,021$36.71$367.9K

View →

Dec 17, 2025Dec 17 3:14 PMChi Michael
Proposed Sale
13,750$36.71$504.8K

View →

Dec 17, 2025Dec 17 2:50 PMBecklund Irene
Proposed Sale
8,411$36.71$308.8K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Apr 6, 2026Apr 7 9:14 PMOluyemi OkupeChief Financial Officer
Option Exercise
3,975$5.01135,587(D)

View →

Mar 20, 2026Mar 24 10:09 PMOluyemi OkupeChief Financial Officer
Option Exercise
4,489$5.01139,562(D)

View →

Mar 13, 2026Mar 17 8:29 PMMichael ChiChief Operating Officer
Option Exercise
72,108127,191(D)

View →

Mar 13, 2026Mar 17 8:29 PMChristiane PendarvisDirector
Option Exercise
15,2110(D)

View →

Mar 13, 2026Mar 17 8:29 PMPatrick Harrison CarrollDirector, Chief Medical Officer
Option Exercise
16,52242,397(D)

View →

Mar 13, 2026Mar 17 8:29 PMDeborah M. AutorDirector, Chief Policy Officer
Option Exercise
32,919493,792(D)

View →

Mar 13, 2026Mar 17 8:29 PMIrene BecklundPAO
Option Exercise
17,98716,714(D)

View →

Mar 13, 2026Mar 17 8:28 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Option Exercise
164,369229,805(D)

View →

Mar 13, 2026Mar 17 8:28 PMSoleil BoughtonChief Legal Officer
Option Exercise
41,42174,194(D)

View →

Mar 13, 2026Mar 17 8:28 PMOluyemi OkupeChief Financial Officer
Option Exercise
105,200137,790(D)

View →

Mar 11, 2026Mar 13 8:20 PMIrene BecklundPAO
Grant/Award
62,07662,076(D)

View →

Mar 11, 2026Mar 13 8:20 PMMichael ChiChief Operating Officer
Grant/Award
376,222376,222(D)

View →

Mar 11, 2026Mar 13 8:20 PMDeborah M. AutorDirector, Chief Policy Officer
Grant/Award
526,711526,711(D)

View →

Mar 11, 2026Mar 13 8:20 PMPatrick Harrison CarrollDirector, Chief Medical Officer
Grant/Award
150,489150,489(D)

View →

Mar 11, 2026Mar 13 8:20 PMSoleil BoughtonChief Legal Officer
Grant/Award
188,111188,111(D)

View →

Mar 11, 2026Mar 13 8:20 PMMohamed ElshenawyCTO
Grant/Award
376,222376,222(D)

View →

Mar 11, 2026Mar 13 8:20 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Grant/Award
413,844413,844(D)

View →

Mar 11, 2026Mar 13 8:20 PMOluyemi OkupeChief Financial Officer
Grant/Award
300,978300,978(D)

View →

Feb 3, 2026Feb 4 9:13 PMOluyemi OkupeChief Financial Officer
Option Exercise
5,262$5.01144,051(D)

View →

Jan 20, 2026Jan 21 9:23 PMOluyemi OkupeChief Financial Officer
Option Exercise
9,067$11.5342,996(D)

View →

← Previous

Page 3 of 3